LH-031

盐酸领克尼斯

Report date: 2022/05/18 17:42:10
NME

Base Information

Drug NameLH-031
Drug Alias Name领克尼斯LH-0314SC-205
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionKinesin-like protein 1 inhibitors
TargetsKinesin-like protein 1
Therapy Area/IndicationsSolid tumoursMultiple MyelomaLymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermanyMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesLink Health Group
Inactive Companies4sc Ag
Active IndicationsMultiple Myeloma
Inactive IndicationsSolid tumoursLymphoma

Other Information

ATC CodeN/A
Related LinksN/A